<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11</volume><submitter>Zhao FY</submitter><funding>National Key Research and Development Program of China</funding><funding>RMIT University</funding><pubmed_abstract>&lt;h4>Background and objective&lt;/h4>Whilst acupuncture is widely used for treating psychosomatic diseases, there is little high-quality evidence supporting its application in comorbid perimenopausal depression (PMD) and insomnia (PMI) which are common complaints during climacteric. This feasibility, patient-assessor-blinded, randomized, sham-controlled clinical trial addresses this gap by investigating the efficacy and safety of acupuncture on depressed mood and poor sleep in women with comorbid PMD and PMI.&lt;h4>Methods&lt;/h4>Seventy eligible participants were randomly assigned to either real-acupuncture (RA) or sham-acupuncture (SA) groups. Either RA or SA treatment were delivered in 17 sessions over 8 weeks. The primary outcomes for mood and sleep were changes on 17-items Hamilton Depression R</pubmed_abstract><journal>Frontiers in public health</journal><pagination>1120567</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9939459</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Acupuncture for comorbid depression and insomnia in perimenopause: A feasibility patient-assessor-blinded, randomized, and sham-controlled clinical trial.</pubmed_title><pmcid>PMC9939459</pmcid><pubmed_authors>Zheng Z</pubmed_authors><pubmed_authors>Fu QQ</pubmed_authors><pubmed_authors>Zhang WJ</pubmed_authors><pubmed_authors>Zhao FY</pubmed_authors><pubmed_authors>Wang HR</pubmed_authors><pubmed_authors>Huang YL</pubmed_authors><pubmed_authors>Jiang T</pubmed_authors><pubmed_authors>Xu H</pubmed_authors><pubmed_authors>Kennedy GA</pubmed_authors><pubmed_authors>Conduit R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Acupuncture for comorbid depression and insomnia in perimenopause: A feasibility patient-assessor-blinded, randomized, and sham-controlled clinical trial.</name><description>&lt;h4>Background and objective&lt;/h4>Whilst acupuncture is widely used for treating psychosomatic diseases, there is little high-quality evidence supporting its application in comorbid perimenopausal depression (PMD) and insomnia (PMI) which are common complaints during climacteric. This feasibility, patient-assessor-blinded, randomized, sham-controlled clinical trial addresses this gap by investigating the efficacy and safety of acupuncture on depressed mood and poor sleep in women with comorbid PMD and PMI.&lt;h4>Methods&lt;/h4>Seventy eligible participants were randomly assigned to either real-acupuncture (RA) or sham-acupuncture (SA) groups. Either RA or SA treatment were delivered in 17 sessions over 8 weeks. The primary outcomes for mood and sleep were changes on 17-items Hamilton Depression R</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-04T20:10:19.82Z</modification><creation>2025-04-04T20:10:19.82Z</creation></dates><accession>S-EPMC9939459</accession><cross_references><pubmed>36815166</pubmed><doi>10.3389/fpubh.2023.1120567</doi></cross_references></HashMap>